Sheng-hong Zhang

58 Zhongshan II Road
Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside.

Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside.

Journal: Inflammatory bowel diseases

Published: September 09, 2020

Classifying Crohn's disease into colon-involving versus non-colon-involving groups is a better predictor of clinical outcomes than the Montreal classification.

Classifying Crohn's disease into colon-involving versus non-colon-involving groups is a better predictor of clinical outcomes than the Montreal classification.

Journal: Therapeutic advances in gastroenterology

Published: May 25, 2020

Nomogram to predict primary non-response to infliximab in patients with Crohn's disease: a multicenter study.

Nomogram to predict primary non-response to infliximab in patients with Crohn's disease: a multicenter study.

Journal: Gastroenterology report

Published: February 01, 2020

Low 6-thioguanine nucleotide level: Effective in maintaining remission in Chinese patients with Crohn's disease.

Low 6-thioguanine nucleotide level: Effective in maintaining remission in Chinese patients with Crohn's disease.

Journal: Journal of gastroenterology and hepatology

Published: January 23, 2018

Different clinical outcomes in Crohn's disease patients with esophagogastroduodenal, jejunal, and proximal ileal disease involvement: is L4 truly a single phenotype?

Different clinical outcomes in Crohn's disease patients with esophagogastroduodenal, jejunal, and proximal ileal disease involvement: is L4 truly a single phenotype?

Journal: Therapeutic advances in gastroenterology

Published: September 08, 2017

Prolonged azathioprine treatment reduces the need for surgery in early Crohn's disease.

Prolonged azathioprine treatment reduces the need for surgery in early Crohn's disease.

Journal: Journal of gastroenterology and hepatology

Published: May 11, 2017

Thiopurines prevented surgical recurrence in patients with Crohn's disease after intestinal resection: Strategy based on risk stratification.

Thiopurines prevented surgical recurrence in patients with Crohn's disease after intestinal resection: Strategy based on risk stratification.

Journal: Journal of gastroenterology and hepatology

Published: March 30, 2017

Over-reaching beyond disease activity: the influence of anxiety and medical economic burden on health-related quality of life in patients with inflammatory bowel disease.

Over-reaching beyond disease activity: the influence of anxiety and medical economic burden on health-related quality of life in patients with inflammatory bowel disease.

Journal: Patient preference and adherence

Published: January 06, 2017

Systematic review with meta-analysis: loss of response and requirement of anti-TNFα dose intensification in Crohn's disease.

Systematic review with meta-analysis: loss of response and requirement of anti-TNFα dose intensification in Crohn's disease.

Journal: Journal of gastroenterology

Published: December 05, 2016

Factors associated with the achievement of mucosal healing in Crohn's disease: the benefit of endoscopic monitoring in treating to target.

Factors associated with the achievement of mucosal healing in Crohn's disease: the benefit of endoscopic monitoring in treating to target.

Journal: Therapeutic advances in gastroenterology

Published: November 27, 2016

Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study.

Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study.

Journal: Therapeutic advances in gastroenterology

Published: November 15, 2016

Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-analysis.

Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-analysis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: March 07, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026